RCMI Coordinating Center (RCMI CC) Header Logo

Connection

William Pelham to Schools

This is a "connection" page, showing publications William Pelham has written about Schools.
Connection Strength

2.313
  1. Fabiano GA, Lupas K, Merrill BM, Schatz NK, Piscitello J, Robertson EL, Pelham WE. Reconceptualizing the approach to supporting students with attention-deficit/hyperactivity disorder in school settings. J Sch Psychol. 2024 Jun; 104:101309.
    View in: PubMed
    Score: 0.826
  2. Sibley MH, Coxe SJ, Campez M, Morley C, Olson S, Hidalgo-Gato N, Gnagy E, Greiner A, Coles EK, Page T, Pelham WE. High versus Low Intensity Summer Treatment for ADHD Delivered at Secondary School Transitions. J Clin Child Adolesc Psychol. 2018 Mar-Apr; 47(2):248-265.
    View in: PubMed
    Score: 0.540
  3. Molina BS, Smith BH, Pelham WE. Development of a school-wide behavior program in a public middle school: an illustration of deployment-focused intervention development, stage 1. J Atten Disord. 2005 Aug; 9(1):333-42.
    View in: PubMed
    Score: 0.226
  4. Lupas KK, Mavrakis A, Altszuler A, Tower D, Gnagy E, MacPhee F, Ramos M, Merrill B, Ward L, Gordon C, Schatz N, Fabiano G, Pelham W. The short-term impact of remote instruction on achievement in children with ADHD during the COVID-19 pandemic. Sch Psychol. 2021 Sep; 36(5):313-324.
    View in: PubMed
    Score: 0.172
  5. Page TF, Pelham WE, Fabiano GA, Greiner AR, Gnagy EM, Hart KC, Coxe S, Waxmonsky JG, Foster EM, Pelham WE. Comparative Cost Analysis of Sequential, Adaptive, Behavioral, Pharmacological, and Combined Treatments for Childhood ADHD. J Clin Child Adolesc Psychol. 2016 Jul-Aug; 45(4):416-27.
    View in: PubMed
    Score: 0.117
  6. Waxmonsky JG, Waschbusch DA, Akinnusi O, Pelham WE. A comparison of atomoxetine administered as once versus twice daily dosing on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Feb; 21(1):21-32.
    View in: PubMed
    Score: 0.083
  7. Di Lonardo Burr SM, LeFevre JA, Arnold LE, Epstein JN, Hinshaw SP, Molina BSG, Hechtman L, Hoza B, Jensen PS, Vitiello B, Pelham WE, Howard AL. Paths to postsecondary education enrollment among adolescents with and without childhood attention-deficit/hyperactivity disorder (ADHD): A longitudinal analysis of symptom and academic trajectories. Child Dev. 2022 09; 93(5):e563-e580.
    View in: PubMed
    Score: 0.045
  8. Fabiano GA, Schatz NK, Lupas K, Gordon C, Hayes T, Tower D, Soto TS, Macphee F, Pelham WE, Hulme K. A school-based parenting program for children with attention-deficit/hyperactivity disorder: Impact on paternal caregivers. J Sch Psychol. 2021 06; 86:133-150.
    View in: PubMed
    Score: 0.042
  9. Sibley MH, Coxe SJ, Page TF, Pelham WE, Yeguez CE, LaCount PA, Barney S. Four-Year Follow-Up of High versus Low Intensity Summer Treatment for Adolescents with ADHD. J Clin Child Adolesc Psychol. 2022 Sep-Oct; 51(5):750-763.
    View in: PubMed
    Score: 0.041
  10. Barbaresi WJ, Campbell L, Diekroger EA, Froehlich TE, Liu YH, O'Malley E, Pelham WE, Power TJ, Zinner SH, Chan E. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr. 2020 Feb/Mar; 41 Suppl 2S:S35-S57.
    View in: PubMed
    Score: 0.039
  11. McIntyre LL, Pelham WE, Kim MH, Dishion TJ, Shaw DS, Wilson MN. A Brief Measure of Language Skills at 3 Years of Age and Special Education Use in Middle Childhood. J Pediatr. 2017 02; 181:189-194.
    View in: PubMed
    Score: 0.031
  12. Baweja R, Belin PJ, Humphrey HH, Babocsai L, Pariseau ME, Waschbusch DA, Hoffman MT, Akinnusi OO, Haak JL, Pelham WE, Waxmonsky JG. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School. J Child Adolesc Psychopharmacol. 2016 Mar; 26(2):154-63.
    View in: PubMed
    Score: 0.029
  13. Kent KM, Pelham WE, Molina BS, Sibley MH, Waschbusch DA, Yu J, Gnagy EM, Biswas A, Babinski DE, Karch KM. The academic experience of male high school students with ADHD. J Abnorm Child Psychol. 2011 Apr; 39(3):451-62.
    View in: PubMed
    Score: 0.021
  14. Waxmonsky JG, Waschbusch DA, Pelham WE, Draganac-Cardona L, Rotella B, Ryan L. Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010 Nov; 71(11):1535-51.
    View in: PubMed
    Score: 0.020
  15. King S, Waschbusch DA, Pelham WE, Frankland BW, Andrade BF, Jacques S, Corkum PV. Social information processing in elementary-school aged children with ADHD: medication effects and comparisons with typical children. J Abnorm Child Psychol. 2009 May; 37(4):579-89.
    View in: PubMed
    Score: 0.018
  16. Waschbusch DA, Pelham WE, Waxmonsky J, Johnston C. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder? J Dev Behav Pediatr. 2009 Apr; 30(2):158-68.
    View in: PubMed
    Score: 0.018
  17. Marshal MP, Molina BS, Pelham WE, Cheong J. Attention-deficit hyperactivity disorder moderates the life stress pathway to alcohol problems in children of alcoholics. Alcohol Clin Exp Res. 2007 Apr; 31(4):564-74.
    View in: PubMed
    Score: 0.016
  18. Foster EM, Jensen PS, Schlander M, Pelham WE, Hechtman L, Arnold LE, Swanson JM, Wigal T. Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res. 2007 Feb; 42(1 Pt 1):165-82.
    View in: PubMed
    Score: 0.016
  19. Fabiano GA, Pelham WE, Waschbusch DA, Gnagy EM, Lahey BB, Chronis AM, Onyango AN, Kipp H, Lopez-Williams A, Burrows-Maclean L. A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples. J Clin Child Adolesc Psychol. 2006 Sep; 35(3):369-85.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support